Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A small, secret panel of experts have been tasked with reviewing crucial data of coronavirus vaccines that U.S. taxpayers have helped fund.
The trial is evaluating an investigational vaccine from Janssen that may require only one shot.
An estimated 60% of Republicans and 46% of Democrats say they wouldn’t get inoculated if a vaccine was available.
FDA weighs whether to resume coronavirus vaccine trial halted due to an adverse event.
A U.K. woman developed spinal inflammation after receiving an adenovirus vector vaccine.
Public health departments are now being told to prepare to distribute COVID-19 vaccines as early as November 1.
More diversity would help doctors determine whether coronavirus treatments and vaccines will work for all population groups.
Advocates claim victory after more than 1,000 people endorse a demand for inclusion.
Four vaccine candidates produced antibody and T-cell immune responses in the first stages of human clinical trials.
Vaccine development is proceeding at an unprecedented pace, but could still hit snags on the way to approval.
The American Cancer Society now calls for vaccination of girls and boys starting at age 9.
Large studies find no evidence that these shots cause autism or other illnesses in kids.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
Intravenous administration allowed the marginally effective BCG vaccination to work better in monkeys.
Hepatitis A is on the rise.
Measles seldom crossed paths with cancer survivors, but now that may change.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.